HM Payson & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $72.9K | Buy |
115
+100
| +667% | +$63.4K | ﹤0.01% | 577 |
|
|
2024
Q4 | $10.7K | Sell |
15
-1
| -6% | -$712 | ﹤0.01% | 835 |
|
|
2024
Q3 | $16.8K | Buy |
16
+15
| +1,500% | +$15.8K | ﹤0.01% | 783 |
|
|
2024
Q2 | $1.05K | Buy |
+1
| New | +$1.05K | ﹤0.01% | 952 |
|
|
2024
Q1 | – | Sell |
-15
| Closed | -$13.2K | – | 999 |
|
|
2023
Q4 | $13.2K | Hold |
15
| – | – | ﹤0.01% | 790 |
|
|
2023
Q3 | $12.3K | Hold |
15
| – | – | ﹤0.01% | 796 |
|
|
2023
Q2 | $10.8K | Hold |
15
| – | – | ﹤0.01% | 795 |
|
|
2023
Q1 | $12.3K | Buy |
+15
| New | +$12.3K | ﹤0.01% | 775 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | -$1K | – | 1065 |
|
|
2022
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1012 |
|
|
2019
Q4 | – | Sell |
-30
| Closed | -$8K | – | 962 |
|
|
2019
Q3 | $8K | Sell |
30
-70
| -70% | -$18.7K | ﹤0.01% | 840 |
|
|
2019
Q2 | $31K | Buy |
+100
| New | +$31K | ﹤0.01% | 674 |
|